Stephen P Ackland (Stephen Ackland)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Asia-Pacific journal of clinical oncology

Clinical pharmacology and therapeutics

BMC cancer

Internal medicine journal

University of Newcastle Faculty of Health

University of Melbourne (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Newcastle Faculty of Health Jan 25 2016

Australia

Professor

University of Newcastle

Australia

Director, Hunter Cancer Research Alliance :: Health

Calvary Mater Newcastle

Australia

Snr Staff Specialist :: Medical Oncology

Education History

University of Melbourne

Australia

BSC

Publications

Cassandra White, Guy Kendall, Tegan Millington, Bern Corcoran, Christine Paul, Rodney J Scott, Stephen P Ackland
Evaluation of early fluoropyrimidine toxicity in solid organ cancer patients: a retrospective observational study in Australia. Internal medicine journal (2024)
Celine Garrett, Daniel Steffens, Stephen P Ackland, Michael Solomon, Cherry Koh
Risk factors, histopathological landscape, biomarkers, treatment patterns and survival of early-onset colorectal cancer: A narrative review. Asia-Pacific journal of clinical oncology (2024)
Celine Garrett, Daniel Steffens, Stephen P Ackland, Michael Solomon, Cherry Koh
Risk factors, histopathological landscape, biomarkers, treatment patterns and survival of early-onset colorectal cancer: A narrative review. Asia-Pacific journal of clinical oncology 20 (4) (2024)
Cassandra White, Rodney J Scott, Christine Paul, Stephen P Ackland
Reply to "Implementation of DPYD Genotyping in Admixed American Populations: Brazil as a Model Case". Clinical pharmacology and therapeutics (2023)
Cassandra White, Rodney J Scott, Christine Paul, Andrew Ziolkowski, David Mossman, Stephen B Fox, Michael Michael, Stephen P Ackland
Dihydropyrimidine Dehydrogenase Deficiency and Implementation of Upfront DPYD Genotyping. Clinical pharmacology and therapeutics 112 (4) (2022)
Luke Ardolino, Aaron Richard Hansen, Stephen P Ackland, Anthony M Joshua
Advanced Adrenocortical Carcinoma (ACC): a Review with Focus on Second-Line Therapies. Hormones & cancer 11 (3-4) (2020)
Philip R Clingan, Stephen P Ackland, Daniel Brungs, Paul de Souza, Morteza Aghmesheh, Madhu B Garg, Richard D Ranson, Suzanne Parker, Rebecca Jokela, Marie Ranson
First-in-human phase I study of infusional and bolus schedules of Deflexifol, a novel 5-fluorouracil and leucovorin formulation, after failure of standard treatment. Asia-Pacific journal of clinical oncology 15 (3) (2019)
Michael B Jameson, Kirsten Gormly, David Espinoza, Wendy Hague, Gholamreza Asghari, Grahame Mark Jeffery, Timothy Jay Price, Christos Stelios Karapetis, Michael Arendse, James Armstrong, John Childs, Frank A Frizelle, Sam Ngan, Andrew Stevenson, Martinus Oostendorp, Stephen P Ackland
SPAR - a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG clinical trial. BMC cancer 19 (1) (2019)

Stephen P Ackland.css-eqlu8i{font-size:small;padding-left:4px;} (Stephen Ackland)

Publication Activity (10 Years)

Top Topics

Top Venues

Stephen P Ackland (Stephen Ackland)